Developer docs
API playgroundTry for free, no card

Search company profiles

Infochem

Full company profile

uuid002vtbc

Namestring
Infochem
Websiteurl
infochem.de
Company typeenum
Private
Founded yearint
1989
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersMunich, Germany
HQ citystring
Munich
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
AI drug synthesis, retrosynthetic route planning, computational chemistry services, pharmaceutical process optimization, chemical manufacturing consulting
Industry3 codes
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
NAICS code1 code
  • Computer Systems Design and Related Services54151
Product category
AI Drug Discovery and Process Chemistry Software
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1AI Route Discovery Services
TypeProfessional Services
Description

B2B service model providing AI-driven synthetic route discovery for pharmaceutical manufacturers. Revenue generated through project-based engagements where ChemAI discovers, validates, and delivers optimized manufacturing routes for client molecules. Model includes discovery, in-silico validation, and lab confirmation phases.

chemai.io
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeSoftware
Software
Core offering1 text field

Infochem provides AI-driven synthetic route discovery and chemistry intelligence for pharmaceutical manufacturers. Its flagship platform ChemAI combines a proprietary AI core called SmartChemistry© with expert chemistry support to evaluate feasibility, optimize routes, and accelerate manufacturing decisions across generic, specialty, originator, and global health programs.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • End-to-end yield improvement from 17% to 42% for Phase III antimalarial candidate
+2 more records
Product overview1 text field

Infochem offers ChemAI as a unified AI-powered platform for synthetic route discovery in the pharmaceutical and chemical manufacturing industries. The platform is anchored by SmartChemistry, a proprietary AI technology that generates and ranks millions of potential synthetic pathways for target molecules. The workflow progresses through four stages: target and constraints definition, AI route discovery, in-silico costing and greenness scoring, and IP/lab validation. The platform serves generic manufacturers, originator companies, and global health programs seeking cost-optimized, patent-defensible synthesis routes.

Product and service1 record
1ChemAI
CategoryAI Drug Discovery and Process Chemistry Software
Description

AI-powered retrosynthetic route planning and process optimization platform built for pharmaceutical manufacturers, enabling faster evaluation of synthetic routes and chemistry feasibility decisions.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move3 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Provider of computational chemistry and molecular simulation platforms used in drug discovery and materials science. Comparable to Infochem because both build physics- and AI-driven software that predicts molecular properties and synthesis behaviour for pharma R&D.

TypeEmerging player
Description

AI-driven drug discovery company with a Chemistry42 generative chemistry platform for molecule design and synthesis prediction. Overlaps with Infochem on AI-enabled chemistry for pharma, though Insilico focuses end-to-end on drug discovery.

TypeBroad incumbent
Description

Enterprise scientific informatics platform used across pharma R&D labs for chemistry, biology, and workflow data. Comparable as an adjacent software vendor serving chemistry and process R&D teams with digital tools.

TypeEmerging player
Description

AI platform for materials and chemicals R&D that uses data-driven models to optimise formulations and processes. Comparable because it applies AI to chemistry engineering workflows, though focused on materials rather than pharma route discovery.

5CAS (Chemical Abstracts Service)
TypeBroad incumbent
Description

Operator of SciFinder and the CAS registry, providing curated chemistry information and predictive retrosynthesis capabilities. Comparable as an established cheminformatics incumbent with overlapping route-discovery and IP clearance use cases.

6Reaxys (Elsevier)
TypeBroad incumbent
Description

Large chemistry database and reaction-search platform widely used in pharma process R&D. Overlaps with Infochem in synthesis-route planning and is a broader incumbent whose reactions database underpins many retrosynthesis tools.

TypeBroad incumbent
Description

Molecular modelling and cheminformatics software provider serving pharma and academic chemistry groups. Comparable as a scientific software vendor whose tools support computational chemistry workflows in drug discovery and development.

8Synthia (formerly Chematica, Merck KGaA)
TypeDirect peer
Description

Retrosynthesis planning software using a curated reaction network and AI/algorithmic search to propose synthesis routes. Direct overlap with Infochem's route-discovery and process-chemistry use cases for pharma and fine chemicals.

TypeDirect peer
Description

AI-driven medicinal chemistry platform offering synthesis planning alongside drug discovery (e.g., COVID Moonshot). Comparable as an AI chemistry company targeting pharma with predictive synthesis and route optimisation workflows.

TypeDirect peer
Description

IBM Research's AI retrosynthesis platform that maps and ranks synthetic routes for target molecules. Directly comparable to SmartChemistry© as a machine-learning-driven forward-synthesis / retrosynthesis tool for chemists.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Infochem

AI Drug Discovery and Process Chemistry Softwareinfochem.de

Infochem firmographics

Firmographics
Name
Infochem
Website
https://infochem.de
Company type
Private
Founded year
1989
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Infochem industry classification

Industry
Product category
AI Drug Discovery and Process Chemistry Software
NAICS
Computer Systems Design and Related Services (54151)
akta.pro industry
PRIMARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAHAA
Small-Molecule API Process Development & Route Scouting
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services
SECONDARYHLAGAHAE
Chiral / Asymmetric Synthesis & Complex Chemistry Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/API & Small-Molecule Development/Manufacturing Services

Keywords

  • AI drug synthesis
  • Retrosynthetic route planning
  • Computational chemistry services
  • Pharmaceutical process optimization
  • Chemical manufacturing consulting

Where Infochem is headquartered

Location

Headquarters

HQ city
Munich
HQ country
Germany
HQ region
Europe

Markets served

Infochem business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

  1. AI Route Discovery Services: B2B service model providing AI-driven synthetic route discovery for pharmaceutical manufacturers. Revenue generated through project-based engagements where ChemAI discovers, validates, and delivers optimized manufacturing routes for client molecules. Model includes discovery, in-silico validation, and lab confirmation phases.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Infochem product offering

Product offering

Core offering

Infochem provides AI-driven synthetic route discovery and chemistry intelligence for pharmaceutical manufacturers. Its flagship platform ChemAI combines a proprietary AI core called SmartChemistry© with expert chemistry support to evaluate feasibility, optimize routes, and accelerate manufacturing decisions across generic, specialty, originator, and global health programs.

Product overview

Infochem offers ChemAI as a unified AI-powered platform for synthetic route discovery in the pharmaceutical and chemical manufacturing industries. The platform is anchored by SmartChemistry, a proprietary AI technology that generates and ranks millions of potential synthetic pathways for target molecules. The workflow progresses through four stages: target and constraints definition, AI route discovery, in-silico costing and greenness scoring, and IP/lab validation. The platform serves generic manufacturers, originator companies, and global health programs seeking cost-optimized, patent-defensible synthesis routes.

Differentiator

Problem solved

Functional benefit

Products and services

  • ChemAI AI-powered retrosynthetic route planning and process optimization platform built for pharmaceutical manufacturers, enabling faster evaluation of synthetic routes and chemistry feasibility decisions.

Quantifiable outcome

  • End-to-end yield improvement from 17% to 42% for Phase III antimalarial candidate
  • +2 more outcomes

Companies that use Infochem

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles1 record

Infochem technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature4 records

Infochem partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves3 records

Expansion highlights4 records

Infochem competitors and assessment

Company assessment

Direct peers

  • Schrödinger: Provider of computational chemistry and molecular simulation platforms used in drug discovery and materials science. Comparable to Infochem because both build physics- and AI-driven software that predicts molecular properties and synthesis behaviour for pharma R&D.
  • Synthia (formerly Chematica, Merck KGaA): Retrosynthesis planning software using a curated reaction network and AI/algorithmic search to propose synthesis routes. Direct overlap with Infochem's route-discovery and process-chemistry use cases for pharma and fine chemicals.
  • PostEra: AI-driven medicinal chemistry platform offering synthesis planning alongside drug discovery (e.g., COVID Moonshot). Comparable as an AI chemistry company targeting pharma with predictive synthesis and route optimisation workflows.
  • IBM RXN: IBM Research's AI retrosynthesis platform that maps and ranks synthetic routes for target molecules. Directly comparable to SmartChemistry© as a machine-learning-driven forward-synthesis / retrosynthesis tool for chemists.

Emerging players

  • Insilico Medicine: AI-driven drug discovery company with a Chemistry42 generative chemistry platform for molecule design and synthesis prediction. Overlaps with Infochem on AI-enabled chemistry for pharma, though Insilico focuses end-to-end on drug discovery.
  • Citrine Informatics: AI platform for materials and chemicals R&D that uses data-driven models to optimise formulations and processes. Comparable because it applies AI to chemistry engineering workflows, though focused on materials rather than pharma route discovery.

Broad incumbents

  • Dotmatics: Enterprise scientific informatics platform used across pharma R&D labs for chemistry, biology, and workflow data. Comparable as an adjacent software vendor serving chemistry and process R&D teams with digital tools.
  • CAS (Chemical Abstracts Service): Operator of SciFinder and the CAS registry, providing curated chemistry information and predictive retrosynthesis capabilities. Comparable as an established cheminformatics incumbent with overlapping route-discovery and IP clearance use cases.
  • Reaxys (Elsevier): Large chemistry database and reaction-search platform widely used in pharma process R&D. Overlaps with Infochem in synthesis-route planning and is a broader incumbent whose reactions database underpins many retrosynthesis tools.
  • OpenEye Scientific (Cadence Molecular Sciences): Molecular modelling and cheminformatics software provider serving pharma and academic chemistry groups. Comparable as a scientific software vendor whose tools support computational chemistry workflows in drug discovery and development.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Infochem social profiles

Digital presence

Infochem financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Infochem leadership team

Management profile

Number of profiles

Infochem funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Infochem M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Infochem

What does Infochem do?

Infochem provides AI-driven synthetic route discovery and chemistry intelligence for pharmaceutical manufacturers. Its flagship platform ChemAI combines a proprietary AI core called SmartChemistry© with expert chemistry support to evaluate feasibility, optimize routes, and accelerate manufacturing decisions across generic, specialty, originator, and global health programs.

When was Infochem founded?

Infochem was founded in 1989. It employs 1 to 10 people.

Where is Infochem based?

Infochem is headquartered in Munich, Germany, in the Europe region.

How does Infochem make money?

One revenue line is on record: AI Route Discovery Services.

Who are Infochem's main competitors?

Direct peers on record are Schrödinger, Synthia (formerly Chematica, Merck KGaA), PostEra and IBM RXN. Emerging players are Insilico Medicine and Citrine Informatics. Broad incumbents are Dotmatics, CAS (Chemical Abstracts Service), Reaxys (Elsevier) and OpenEye Scientific (Cadence Molecular Sciences).

Does Infochem have an API?

No public API is recorded for Infochem.

What industry is Infochem in?

Infochem's product category is AI Drug Discovery and Process Chemistry Software. Its primary akta.pro industry code is HLAGAJAO, AI/ML Platforms for Drug Discovery & Experiment Optimization, with a secondary code of HLAGAHAA, Small-Molecule API Process Development & Route Scouting. Its NAICS code is 54151.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales